Clonal	0	5
strains	7	13
of	15	16
Pseudomonas	18	28
aeruginosa	30	39
in	41	42
paediatric	44	53
and	55	57
adult	59	63
cystic	65	70
fibrosis	72	79
units	81	85
.	86	86

Despite	88	94
recent	96	101
reports	103	109
of	111	112
clonal	114	119
strains	121	127
of	129	130
Pseudomonas	132	142
aeruginosa	144	153
in	155	156
cystic	158	163
fibrosis	165	172
(	174	174
CF	175	176
)	177	177
units	179	183
,	184	184
the	186	188
need	190	193
for	195	197
routine	199	205
microbiological	207	221
surveillance	223	234
remains	236	242
contentious	244	254
.	255	255

Sputum	257	262
was	264	266
collected	268	276
prospectively	278	290
from	292	295
productive	297	306
patients	308	315
attending	317	325
the	327	329
regional	331	338
paediatric	340	349
and	351	353
adult	355	359
CF	361	362
units	364	368
in	370	371
Brisbane	373	380
,	381	381
Australia	383	391
.	392	392

All	394	396
P	398	398
.	399	399
aeruginosa	401	410
isolates	412	419
were	421	424
typed	426	430
using	432	436
pulsed	438	443
-	444	444
field	445	449
gel	451	453
electrophoresis	455	469
.	470	470

Spirometry	472	481
,	482	482
anthropometrics	484	498
,	499	499
hospitalisations	501	516
and	518	520
antibiotic	522	531
sensitivity	533	543
data	545	548
were	550	553
recorded	555	562
.	563	563

The	565	567
first	569	573
100	575	577
sputum	579	584
samples	586	592
(	594	594
first	595	599
50	601	602
patients	604	611
at	613	614
each	616	619
clinic	621	626
)	627	627
harboured	629	637
163	639	641
isolates	643	650
of	652	653
P	655	655
.	656	656
aeruginosa	658	667
.	668	668

A	670	670
total	672	676
of	678	679
39	681	682
patients	684	691
shared	693	698
a	700	700
common	702	707
strain	709	714
(	716	716
pulsotype	717	725
2	727	727
)	728	728
,	729	729
20	731	732
patients	734	741
shared	743	748
a	750	750
strain	752	757
with	759	762
at	764	765
least	767	771
one	773	775
other	777	781
patient	783	789
and	791	793
41	795	796
patients	798	805
harboured	807	815
unique	817	822
strains	824	830
.	831	831

Eight	833	837
patients	839	846
shared	848	853
a	855	855
strain	857	862
identical	864	872
to	874	875
a	877	877
previously	879	888
reported	890	897
Australian	899	908
transmissible	910	922
strain	924	929
(	931	931
pulsotype	932	940
1	942	942
)	943	943
.	944	944

Compared	946	953
with	955	958
the	960	962
unique	964	969
strain	971	976
group	978	982
,	983	983
patients	985	992
harbouring	994	1003
pulsotype	1005	1013
2	1015	1015
were	1017	1020
younger	1022	1028
and	1030	1032
had	1034	1036
poorer	1038	1043
lung	1045	1048
function	1050	1057
.	1058	1058

Treatment	1060	1068
requirements	1070	1081
were	1083	1086
similar	1088	1094
in	1096	1097
these	1099	1103
two	1105	1107
groups	1109	1114
,	1115	1115
as	1117	1118
were	1120	1123
the	1125	1127
rates	1129	1133
of	1135	1136
multiresistance	1138	1152
.	1153	1153

In	1155	1156
conclusion	1158	1167
,	1168	1168
59	1170	1171
%	1172	1172
of	1174	1175
patients	1177	1184
harboured	1186	1194
a	1196	1196
clonal	1198	1203
strain	1205	1210
,	1211	1211
supporting	1213	1222
the	1224	1226
need	1228	1231
for	1233	1235
routine	1237	1243
microbiological	1245	1259
surveillance	1261	1272
.	1273	1273

In	1275	1276
contrast	1278	1285
to	1287	1288
previously	1290	1299
described	1301	1309
clonal	1311	1316
strains	1318	1324
,	1325	1325
the	1327	1329
dominant	1331	1338
pulsotype	1340	1348
was	1350	1352
indistinguishable	1354	1370
from	1372	1375
nonclonal	1377	1385
strains	1387	1393
with	1395	1398
respect	1400	1406
to	1408	1409
both	1411	1414
colonial	1416	1423
morphology	1425	1434
and	1436	1438
multiresistance	1440	1454
.	1455	1455

The	1457	1459
clinical	1461	1468
significance	1470	1481
of	1483	1484
clonal	1486	1491
strains	1493	1499
remains	1501	1507
uncertain	1509	1517
and	1519	1521
requires	1523	1530
longitudinal	1532	1543
study	1545	1549
.	1550	1550
